Skip to main content

Table 2 Breakdown of All Antimicrobials Prescribed for Outpatient Parenteral Antimicrobial Therapy

From: Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study

Antimicrobial Total
(N = 200)
Readmitted
(n = 42)
Not Readmitted
(n = 158)
Penicillins 31 (15.5) 10 (23.8) 21 (13.3)
 Ampicillin 4 (12.9) 1 (10) 3 (14.3)
 Ampicillin/sulbactam 6 (19.3) 4 (40) 2 (9.5)
 Nafcillin 5 (16.1) 0 (0) 5 (23.8)
 Oxacillin 3 (9.7) 2 (20) 1 (4.76)
 Penicillin G (parenteral/aqueous) 6 (19.3) 1 (10) 5 (23.8)
 Piperacillin/tazobactam 7 (22.6) 2 (20) 5 (23.8)
Cephalosporins 81 (40.5) 13 (31.0) 68 (43.0)
 Cefazolin 12 (14.8) 3 (23.1) 9 (13.2)
 Cefepime 22 (27.2) 2 (15.4) 20 (29.4)
 Ceftaroline fosamil 6 (7.4) 1 (7.7) 5 (7.4)
 Ceftazidime 3 (3.7) 0 (0) 3 (4.4)
 Ceftriaxone 38 (46.9) 7 (53.8) 31 (45.6)
Carbapenemsa 46 (23) 8 (19.0) 38 (24.1)
 Ertapenem 30 (65.2) 4 (50) 26 (68.4)
 Imipenem/cilastatin 3 (6.5) 0 (0) 3 (7.9)
 Meropenem 14 (30.4) 4 (50) 10 (26.3)
Aminoglycosides (gentamicin) 1 (0.5) 0 (0) 1 (0.6)
Fluoroquinolones (ciprofloxacin) 2 (1) 0 (0) 2 (1.3)
Clindamycin 1 (0.5) 0 (0) 1 (0.6)
Daptomycin 5 (2.5) 2 (4.8) 3 (1.9)
Metronidazole 2 (1) 0 (0) 2 (1.3)
Vancomycin 62 (31) 12 (28.6) 50 (31.6)
Antivirals 4 (2) 1 (2.4) 3 (1.9)
 Acyclovir 2 (50) 0 (0) 2 (66.7)
 Foscarnet 2 (50) 1 (100) 1 (33.3)
  1. All values expressed as n (%)
  2. aOne patient received both meropenem and ertapenem (to start ertapenem after course of meropenem complete)